-
1
-
-
0028568541
-
The emerging fungal threat
-
Steraberg S. The emerging fungal threat. Science 1994;266:1632-4.
-
(1994)
Science
, vol.266
, pp. 1632-1634
-
-
Steraberg, S.1
-
2
-
-
0002342161
-
Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils
-
Lehrer RI. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils. Infect Immun 1970;2:42-7.
-
(1970)
Infect Immun
, vol.2
, pp. 42-47
-
-
Lehrer, R.I.1
-
3
-
-
0023243761
-
Candidacidal activity of monocyte-derived macrophages: Relationship between Candida killing and oxygen radical generation by human macrophages
-
Sasada M, Kubo A, Nishimura T, et al. Candidacidal activity of monocyte-derived macrophages: relationship between Candida killing and oxygen radical generation by human macrophages. J Leukoc Biol 1987;41:289-94.
-
(1987)
J Leukoc Biol
, vol.41
, pp. 289-294
-
-
Sasada, M.1
Kubo, A.2
Nishimura, T.3
-
5
-
-
0025264091
-
Fluconazole and other azoles: Translation of in vitro activity to in vivo and clinical efficacy
-
Troke PF, Andrews RJ, Pye GW, Richardson K. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Rev Infect Dis 1990;12(suppl 1):S276-80.
-
(1990)
Rev Infect Dis
, vol.12
, Issue.1 SUPPL.
-
-
Troke, P.F.1
Andrews, R.J.2
Pye, G.W.3
Richardson, K.4
-
6
-
-
0022475070
-
Activity of fluconazole (UK 49858) and ketoconazole against Candida albicans in vitro and in vivo
-
Rogers TE, Galgiani JN. Activity of fluconazole (UK 49858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother 1986;30:418-22.
-
(1986)
Antimicrob Agents Chemother
, vol.30
, pp. 418-422
-
-
Rogers, T.E.1
Galgiani, J.N.2
-
7
-
-
0028862273
-
Synergy of fluconazole with human monocyte-derived macrophages for killing Candida species
-
Garcha UK, Brummer E, Stevens DA. Synergy of fluconazole with human monocyte-derived macrophages for killing Candida species. J Infect Dis 1995;172:1620-3.
-
(1995)
J Infect Dis
, vol.172
, pp. 1620-1623
-
-
Garcha, U.K.1
Brummer, E.2
Stevens, D.A.3
-
8
-
-
0027448391
-
Multicenter evaluation of broth macrodilution antifungal susceptibility test for yeasts
-
Fromtling RA, Galgiani JN, Pfaller MA, et al. Multicenter evaluation of broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 1993;37:39-45.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 39-45
-
-
Fromtling, R.A.1
Galgiani, J.N.2
Pfaller, M.A.3
-
9
-
-
0028365124
-
Macrophage colony-stimulating factor induction of enhanced anticryptococcal activity with fluconazole for killing
-
Brummer E, Stevens DA. Macrophage colony-stimulating factor induction of enhanced anticryptococcal activity with fluconazole for killing. J Infect Dis 1994;170:173-9.
-
(1994)
J Infect Dis
, vol.170
, pp. 173-179
-
-
Brummer, E.1
Stevens, D.A.2
-
10
-
-
0014153849
-
Relationship of transferrin and iron to serum inhibition of Candida albicans
-
Esterly NB, Brammer SR, Crounse RC. Relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Dermatol 1967;49:437-42.
-
(1967)
J Invest Dermatol
, vol.49
, pp. 437-442
-
-
Esterly, N.B.1
Brammer, S.R.2
Crounse, R.C.3
-
11
-
-
0014589650
-
Elevated serum iron, low unbound transferrin, and candidiasis in acute leukemia
-
Caroline L, Rosner F, Kozinn PJ. Elevated serum iron, low unbound transferrin, and candidiasis in acute leukemia. Blood 1969;34:441-51.
-
(1969)
Blood
, vol.34
, pp. 441-451
-
-
Caroline, L.1
Rosner, F.2
Kozinn, P.J.3
|